- Home
- BMY vs TD Comparison
BMY vs TD Comparison
Compare BMY & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- TD
- Stock Information
- Founded
- BMY 1887
- TD 1855
- Country
- BMY United States
- TD Canada
- Employees
- BMY N/A
- TD N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- TD
- Sector
- BMY Health Care
- TD
- Exchange
- BMY Nasdaq
- TD Nasdaq
- Market Cap
- BMY 120.5B
- TD 105.0B
- IPO Year
- BMY N/A
- TD N/A
- Fundamental
- Price
- BMY $61.10
- TD $59.55
- Analyst Decision
- BMY Hold
- TD Buy
- Analyst Count
- BMY 14
- TD 2
- Target Price
- BMY $58.00
- TD $83.50
- AVG Volume (30 Days)
- BMY 12.2M
- TD 1.9M
- Earning Date
- BMY 04-24-2025
- TD 02-27-2025
- Dividend Yield
- BMY 4.06%
- TD 4.95%
- EPS Growth
- BMY N/A
- TD N/A
- EPS
- BMY N/A
- TD 3.26
- Revenue
- BMY $48,300,000,000.00
- TD $36,873,924,749.00
- Revenue This Year
- BMY N/A
- TD $7.41
- Revenue Next Year
- BMY N/A
- TD $4.71
- P/E Ratio
- BMY N/A
- TD $18.23
- Revenue Growth
- BMY 7.32
- TD 0.91
- 52 Week Low
- BMY $39.35
- TD $51.25
- 52 Week High
- BMY $63.10
- TD $64.91
- Technical
- Relative Strength Index (RSI)
- BMY 65.95
- TD 57.51
- Support Level
- BMY $59.03
- TD $57.91
- Resistance Level
- BMY $60.69
- TD $59.85
- Average True Range (ATR)
- BMY 1.47
- TD 0.91
- MACD
- BMY 0.46
- TD -0.22
- Stochastic Oscillator
- BMY 79.08
- TD 56.36
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, US retail banking, and wholesale banking. The bank's US operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 10.1% ownership stake in Charles Schwab.